Literature DB >> 18071779

High sensitivity C-reactive protein and endothelial function in Chilean patients with history of Kawasaki disease.

Arturo Borzutzky1, Miguel Gutiérrez, Eduardo Talesnik, Iván Godoy, Jonathan Kraus, Rodrigo Hoyos, Pilar Arnaiz, Mónica Acevedo.   

Abstract

Kawasaki disease (KD) produces endothelial inflammation, which may lead to dilatation and aneurysms of coronary and peripheral arteries. Previous studies have suggested that these patients can present endothelial dysfunction that can predispose to coronary vascular events late after KD. The purpose of this study was to determine the cardiovascular risk profile and endothelial function of Chilean children with history of KD. In a prospective case-control study, 11 patients with history of KD (age 10.6 +/- 2.0 years, interval from initial episode 8.1 +/- 3.6 years) and 11 healthy, age-, gender-, and BMI z score-matched controls were evaluated with blood pressure (BP), a fasting lipid profile, high sensitivity C-reactive protein (hsCRP), and flow-mediated dilatation of the brachial artery (FMD). One KD patient (9.1%) had persistent coronary aneurysms. There was a significant difference of mean and log-transformed concentrations of hsCRP between case and control groups (2.3 +/- 3.0 vs 0.5 +/- 0.3 mg/l, P = 0.045). None of the patients with elevated hsCRP had persistent coronary arterial lesions. No difference was found in systolic BP z score between the case and control groups. Diastolic BP z score was significantly higher in cases than controls (P = 0.039). There were no significant differences of FMD between cases and controls. Mean fasting total cholesterol, high-density and low-density lipoprotein, and triglycerides in cases were normal, with no significant difference vs controls. This study shows that Chilean children with history of KD have increased levels of hsCRP, possibly reflecting persistent low-grade inflammation. The prognostic value of hsCRP in KD patients deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18071779     DOI: 10.1007/s10067-007-0808-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  25 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents.

Authors: 
Journal:  Pediatrics       Date:  1992-03       Impact factor: 7.124

3.  The metabolic syndrome and concentrations of C-reactive protein among U.S. youth.

Authors:  Earl S Ford; Umed A Ajani; Ali H Mokdad
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

4.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

5.  Endothelial function evaluated by flow-mediated dilatation in pediatric vascular disease.

Authors:  T Kadono; H Sugiyama; M Hoshiai; M Osada; T Tan; A Naitoh; M Watanabe; K Koizumi; S Nakazawa
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

6.  Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease.

Authors:  Y F Cheung; M H K Ho; S C F Tam; T C Yung
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

7.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

8.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Authors:  H Kato; T Sugimura; T Akagi; N Sato; K Hashino; Y Maeno; T Kazue; G Eto; R Yamakawa
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

9.  C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000.

Authors:  Earl S Ford; Wayne H Giles; Gary L Myers; Nader Rifai; Paul M Ridker; David M Mannino
Journal:  Clin Chem       Date:  2003-08       Impact factor: 8.327

10.  Altered lipid profile after Kawasaki syndrome.

Authors:  J W Newburger; J C Burns; A S Beiser; J Loscalzo
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

View more
  12 in total

Review 1.  Meta-analysis of risk factors associated with atherosclerosis in patients with Kawasaki disease.

Authors:  Han Zhang; Ming-Guo Xu; Li-Jian Xie; Min Huang; Jie Shen; Ting-Ting Xiao
Journal:  World J Pediatr       Date:  2016-06-29       Impact factor: 2.764

2.  Orthostatic and Exercise Effects in Children Years After Kawasaki Disease.

Authors:  Yoshihiro Nakamura; Takehiro Hama; Yoshie Nakamura; Hideki Tsukada; Yoichiro Oda; Shoichi Awa
Journal:  Pediatr Cardiol       Date:  2019-10-08       Impact factor: 1.655

3.  High Sensitivity C Reactive Protein (hs-CRP) in Adolescent and Young Adult Patients with History of Kawasaki Disease.

Authors:  Yung-Chuan Chen; Ching-Tsuen Shen; Nan-Koong Wang; Yi-Ling Huang; Hsin-Hui Chiu; Chun-An Chen; Shuenn-Nan Chiu; Ming-Tai Lin; Jou-Kou Wang; Mei-Hwan Wu
Journal:  Acta Cardiol Sin       Date:  2015-11       Impact factor: 2.672

4.  First report on the lipid profile late after kawasaki disease in Iranian children.

Authors:  Seyyed-Naserredin Mostafavi; Elham Barzegar; Nayereh Siyah Manssori; Roya Kelishadi
Journal:  Int J Prev Med       Date:  2014-07

5.  The number and function of circulating endothelial progenitor cells in patients with Kawasaki disease.

Authors:  Ming-Guo Xu; Li-Na Men; Chun-Yu Zhao; Xia Zhao; Yuan-Xiang Wang; Xiang-Chun Meng; Ding-Rong Shen; Bao-Ying Meng; Qing Zhang; Tao Wang
Journal:  Eur J Pediatr       Date:  2009-06-23       Impact factor: 3.183

Review 6.  Endothelial function in pre-pubertal children at risk of developing cardiomyopathy: a new frontier.

Authors:  Aline Cristina Tavares; Edimar Alcides Bocchi; Guilherme Veiga Guimarães
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 7.  Peripheral Endothelial (Dys)Function, Arterial Stiffness and Carotid Intima-Media Thickness in Patients after Kawasaki Disease: A Systematic Review and Meta-Analyses.

Authors:  Sanne M Dietz; Carline E A Tacke; Barbara A Hutten; Taco W Kuijpers
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

8.  Persistence of endothelial cell damage late after Kawasaki disease in patients without coronary artery complications.

Authors:  Nasser Mostafavi; Shaghayegh Haghjooy-Javanmard; Nahid Presidend; Nayereh Siyah Manssori; Roya Kelishadi
Journal:  Adv Biomed Res       Date:  2015-01-30

9.  The role of peroxisome proliferator-activated receptor gamma and adiponectin in children with Kawasaki disease.

Authors:  Ji-Yong Zhang; Hong Peng; Si-Tang Gong; Yong-Mei Zeng; Miao Huang; Pei-Hui Liu; Li-Ting Wang; Guo-Qing Dong
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

10.  Does Vitamin C improve endothelial function in patients with Kawasaki disease?

Authors:  Mohammad Reza Sabri; Esfandiar Najafi Tavana; Alireza Ahmadi; Naser Mostafavy
Journal:  J Res Med Sci       Date:  2015-01       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.